Company No:
Contents
| Note | 30.06.2025 | 30.06.2024 | ||
| £ | £ | |||
| Fixed assets | ||||
| Investments | 3 |
|
|
|
| 2,040,000 | 2,040,000 | |||
| Current assets | ||||
| Debtors | 4 |
|
|
|
| Cash at bank and in hand |
|
|
||
| 28,878 | 21,867 | |||
| Creditors: amounts falling due within one year | 5 | (
|
(
|
|
| Net current liabilities | (13,628) | (2,042,733) | ||
| Total assets less current liabilities | 2,026,372 | (2,733) | ||
| Net assets/(liabilities) |
|
(
|
||
| Capital and reserves | ||||
| Called-up share capital | 7 |
|
|
|
| Profit and loss account | (
|
(
|
||
| Total shareholder's funds/(deficit) |
|
(
|
Directors' responsibilities:
The financial statements of Swartland Holdco Limited (registered number:
|
J F Hanekom
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.
Swartland Holdco Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, TR1 2NA, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Financial assets
Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.
For financial assets carried at amortised cost, the amount of impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.
For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.
Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
| Year ended 30.06.2025 |
Period from 02.08.2023 to 30.06.2024 |
||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including directors |
|
|
| Loans | Other investments | Total | |||
| £ | £ | £ | |||
| Cost or valuation before impairment | |||||
| At 01 July 2024 |
|
|
|
||
| At 30 June 2025 |
|
|
|
||
| Carrying value at 30 June 2025 |
|
|
|
||
| Carrying value at 30 June 2024 |
|
|
|
Investments in shares
The following were investments in the shares of the Company:
| Name of entity | Registered office | Principal activity | Class of shares |
Ownership 30.06.2025 |
|
|
7 Cliffe Park Way, Bruntcliffe Road, Morley, Leeds, England, LS27 0RY | Property investment |
|
|
|
|
7 Cliffe Park Way, Bruntcliffe Road, Morley, Leeds, LS27 0RY | Property investment |
|
|
| 30.06.2025 | 30.06.2024 | ||
| £ | £ | ||
| Deferred tax asset |
|
|
|
| Other debtors |
|
|
|
|
|
|
| 30.06.2025 | 30.06.2024 | ||
| £ | £ | ||
| Trade creditors |
|
|
|
| Other creditors |
|
|
|
|
|
|
| 30.06.2025 | 30.06.2024 | ||
| £ | £ | ||
| At the beginning of financial year/period |
|
|
|
| Credited to the Statement of Income and Retained Earnings |
|
|
|
| At the end of financial year/period |
|
|
| 30.06.2025 | 30.06.2024 | ||
| £ | £ | ||
| Allotted, called-up and fully-paid | |||
|
|
|
|
Transactions with owners holding a participating interest in the entity
| 30.06.2025 | 30.06.2024 | ||
| £ | £ | ||
| Swartland Eiendomme (PTY) Ltd | 0 | (2,061,000) |
Other creditors of £2,061,000 in 2024 related to an advance received from Swartland Eiendomme (Pty) Ltd in anticipation of the issue of additional share capital. Due to an administrative oversight, the documentation required to issue the new shares was not completed before year end. The Company allotted 2,061,000 Ordinary £1 shares, with an aggregate value of £2,061,000, on 23 April 2025, prior to the approval of the 2024 financial statements. This balance did not represent a loan. Following the allotment, the amount has been reclassified to share capital.